Variant · Snv
C3 NM_000064.4(C3):c.2430G>A (p.Ser810=)
CI-VAR-00053435Explore in graph →p.Ser810=NM_000064.4:c.2430G>AClinVar 330304 rs2230207
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 330304 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Atypical hemolytic-uremic syndrome with C3 anomaly; Complement component 3 deficiency; Age related macular degeneration 9; Colon adenocarcinoma; Ovarian serous cystadenocarcinoma; Lung cancer; Clear cell carcinoma of kidney; Gastric cancer; Adrenocortical carcinoma, hereditary; Cervical cancer; Uterine carcinosarcoma; Thymoma; Thyroid cancer, nonmedullary, 1; Cholangiocarcinoma; Hepatocellular carcinoma | germline | 9 | Feb 02, 2026 | clinvar |